A Congressional committee found Medicare Advantage overpays insurers by $212 per enrollee, totaling about $7 billion annually. This overpayment funds insurer profits and supplemental benefits like dental and vision care, which traditional Medicare lacks. The excess stems from risk adjustment coding, payment benchmarks, and upcoding practices. While CMS audits and DOJ probes are increasing, Medicare Advantage payments are set to rise in 2027, potentially reducing supplemental benefits and changing plan attractiveness for retirees.
Mizuho increased its price target for UnitedHealth Group from $410 to $440, maintaining an Outperform rating due to signs that medical cost pressures are easing in the managed care sector. The move reflects confidence that the challenging medical los...
UnitedHealth's shares surged 20% over the past month, trading around $389, driven by stronger-than-expected Q1 2026 results with revenue up 2% to $111.7 billion and adjusted EPS of $7.23. Despite Berkshire Hathaway's exit from its UNH stake, the comp...
Humana's stock has surged 48% over the past month, outperforming peers like UnitedHealth and Cigna, driven by strong Medicare Advantage (MA) growth and favorable regulatory decisions. The company reported Q1 2026 adjusted EPS of $10.31, beating estim...
